"Innovation and Supply Center" public legal entity (PLE) will purchase injectable antidiabetic and oral hypoglycemic drugs within the framework of expenses related to measures for diabetes mellitus.
Medianews.az reports that the organization has announced a tender regarding this matter.
The PLE will pay 37,645,943 manats and 95 qəpik in exchange for insulin and medicinal products to be purchased for diabetic patients. /Oxu.az